Skip to main content
USA News
  2016-06-29
CE Mark brings the increased functionality of the AtriClip PRO2 device to the European market for use in managing the left atrial appendage; product was launched in the U.S. in April 2016 MASON, Ohio --(BUSINESS WIRE)--Jun. 29, 2016-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in
  2016-01-19
Approval opens up a new market for the most widely implanted left atrial appendage occlusion device in the world WEST CHESTER, Ohio --(BUSINESS WIRE)--Jan. 19, 2016-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA)
  2013-10-01
AMSTERDAM, Netherlands --(BUSINESS WIRE)--Oct. 1, 2013-- AtriCure, Inc. ( Nasdaq: ATRC ), is partnering with leading atrial fibrillation (Afib) centers and thought leaders across Europe to provide best-in-class training on surgical ablation. The launch of an international Maze IV Training program